Fig. 5From: Development and validation of a point-based scoring system for predicting axillary lymph node metastasis and disease outcome in breast cancer using clinicopathological and multiparametric MRI featuresKaplan–Meier recurrence-free survival (RFS) analyses of the low-risk and high-risk groups in the PSS. The high-risk group patients had a significantly worse RFS than the low-risk groups patients in both the primary cohort (A) and validation cohort (B)Back to article page